No plans to enter vaccine production as it needs different manufacturing infra: Dilip Sanghvi Read more
CSIR, Laxai Life Sciences get DCGI nod for clinical trials of Colchicine on COVID-19 patients Read more
Bharat Biotech gets $15 mn upfront from Ocugen for rights to commercialise Covaxin in Canada Read more